Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Christian Angermayer
AddedMar 31, 2024
UpdatedJun 28, 2026
Christian Angermayer

Christian Angermayer

Founder, re.Mind Capital

CrunchbaseLinkedIn

Christian Angermayer's Career

re.Mind Capital
re.Mind Capital

Sliema, Sliema, MT

Founder
Finlab
Finlab

Frankfurt, Hesse, DE

Founder
Apeiron Investment Group
Apeiron Investment Group

Sliema, Sliema, MT

Founder & CEO· C-Suite · Management
Presight Capital
Presight Capital

West Hollywood, CA, US

Co-Founder
Blackrock Neurotech
Blackrock Neurotech

Salt Lake City, UT, US

Board Member· Board
Cambrian BioPharma
Cambrian BioPharma

New York City, NY, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Christian Angermayer's Career

re.Mind Capital
re.Mind Capital
Fund72020Sliema, Sliema, MT
Founder
Finlab
Finlab
Investment FirmInvestment Firm$11.1M92005Frankfurt, Hesse, DE
Founder

Recent news

South Korea’s ‘Silicon Valley’ strives to live up to its global ambitionsTechCrunch · 2025

Leadership at Finlab

Volker RofalskiVolker RofalskiBoard Member
Herbert SeulingHerbert SeulingBoard Member
Stefan MuellerStefan MuellerBoard Member
Axel-Guenter BenknerAxel-Guenter BenknerBoard Member

Similar to Finlab

Purple VenturesPurple VenturesBrno, South Moravian Region, CZest. 2019Purple VenturesBrno, South Moravian Region, CZ · est. 2019

European VC fund providing seed investments to promising early-stage fintech startups.

Investment Firm8
VentureLaboInvestmentVentureLaboInvestmentTokyo, Tokyo, JPest. 1999VentureLaboInvestmentTokyo, Tokyo, JP · est. 1999

Venture Labo Investment: A venture capital firm supporting companies at every growth stage.

Investment Firm6
Finlab EOS VCFinlab EOS VCFrankfurt, Hesse, DEest. 2018Finlab EOS VCFrankfurt, Hesse, DE · est. 2018

Global financial tech partnership leveraging blockchain.

Investment Firm5
FinbergFinbergIstanbul, Istanbul Province, TRest. 2018FinbergIstanbul, Istanbul Province, TR · est. 2018

Finberg, a Fibabanka subsidiary, is a corporate venture capital firm established in 2018.

Investment Firm11
Apeiron Investment Group
Apeiron Investment Group
Investment FirmInvestment Firm302012Sliema, Sliema, MT
Founder & CEO· C-Suite · Management
Presight Capital
Presight Capital
Investment FirmInvestment Firm52019West Hollywood, CA, US
Co-Founder

Leadership at Presight Capital

Fabian HansenFabian HansenCo-Founder

Similar to Presight Capital

Foresite CapitalForesite CapitalSan Francisco, CA, USest. 2011Foresite CapitalSan Francisco, CA, US · est. 2011

Foresite Capital: A leading US venture capital & growth equity firm, headquartered in San Francisco.

Investment Firm68
Preface VenturesPreface VenturesNew York City, NY, USest. 2021Preface VenturesNew York City, NY, US · est. 2021

Preface Ventures: A full-service investment firm, partnering with Frontier Enterprises, investing $500k-$1M in pre/seed rounds.

Investment Firm9
Start CapitalStart CapitalLondon, Greater London, GBest. 2010Start CapitalLondon, Greater London, GB · est. 2010

Start Capital: A global venture capital firm investing in visionary startups, offering guidance and industry disruption.

Investment Firm4
Precursor VenturesPrecursor VenturesSan Francisco, CA, USest. 2015Precursor VenturesSan Francisco, CA, US · est. 2015

Early-stage venture firm, Precursor Ventures, specializes in seed investing across various sectors since 2015.

Investment Firm11
Blackrock Neurotech
Blackrock Neurotech
Series B$220M1732008Salt Lake City, UT, US
Board Member· Board

Recent news

Tether Takes Strategic Stake in Brain-Computer Interface Company Blackrock NeurotechTether · 2024
Blackrock Neurotech's MoveAgain Brain-Computer Interface System Receives FDA Breakthrough Device DesignationPR Newswire · 2021
Blackrock Neurotech Closes $10M Financing Round to Advance BCI TechnologyPR Newswire · 2021

Leadership at Blackrock Neurotech

Marcus GerhardtMarcus GerhardtChief Executive Officer
Tim SieversTim SieversBoard Member
Florian SolzbacherFlorian SolzbacherChief Scientific Officer
Jan HardorpJan HardorpBoard Member

Similar to Blackrock Neurotech

NeuralinkNeuralinkFremont, CA, USBrain Computer Interfacesest. 2016NeuralinkFremont, CA, US · est. 2016

Neuralink Corp., a US-based neurotech firm, innovates brain-computer interfaces for human-computer synergy.

Series D · $686.2M300
Precision NeurosciencePrecision NeuroscienceNew York City, NY, USBrain Computer Interfacesest. 2021Precision NeuroscienceNew York City, NY, US · est. 2021

Precision Neuroscience: Pioneering minimally invasive brain-computer interfaces for neurological treatments.

Series B · $53M34
NeurolutionsNeurolutionsSt. Louis, MO, USMedical Devicesest. 2007NeurolutionsSt. Louis, MO, US · est. 2007

Neurolutions, Inc.: Innovating thought-controlled devices for neurological injury recovery.

Pre-Seed · $1.3M10
Cambrian BioPharma
Cambrian BioPharma
Late Stage Private$160M302019New York City, NY, US
Co-Founder

Recent news

TechCrunch Live events, but a podcastTechCrunch · 2023

Leadership at Cambrian BioPharma

Sebastian A. BrunemeierSebastian A. BrunemeierCo-Founder
Maryanna SaenkoMaryanna SaenkoBoard Member
Paul FarrPaul FarrBoard Member
James PeyerJames PeyerCo-Founder
Brent SaundersBrent SaundersBoard Member

Similar to Cambrian BioPharma

Rejuveron Life SciencesRejuveron Life SciencesSchlieren, Zürich, CHDrug Development, Therapiesest. 2019Rejuveron Life SciencesSchlieren, Zürich, CH · est. 2019

Rejuveron Life Sciences: A biotech platform investing in innovative therapies for healthy aging.

Late Stage Private · $97.6M22
Retro BiosciencesRetro BiosciencesSan Francisco, CA, USTherapeuticsest. 2021Retro BiosciencesSan Francisco, CA, US · est. 2021

Retro Biosciences, an American medical firm, pioneers in cellular reprogramming and plasma-inspired therapeutics.

Late Stage Private · $180M44
Regenerative BioRegenerative BioCambridge, MA, USPharmaceuticalsest. 2020Regenerative BioCambridge, MA, US · est. 2020

Regenerative Bio: AI-driven biotech firm pioneering anti-aging solutions through pharmaceutical tech.

Angel · $10M13
BioAge LabsBioAge LabsRichmond, CA, USDrug Developmentest. 2015BioAge LabsRichmond, CA, US · est. 2015

BioAge Labs builds software and services for its target customers and markets.

Series C · $123.9M175

Christian Angermayer's Co-Investors

Edward LandoEdward LandoCo-invested · Batelle AngelJeff CruttendenJeff CruttendenCo-invested · Batelle AngelJon OringerJon OringerCo-invested · Batelle AngelNadav Ben-ChanochNadav Ben-ChanochCo-invested · Batelle AngelTaavet HinrikusTaavet HinrikusCo-invested · Batelle Angel

Christian Angermayer's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · Dunamu

People Similar to Christian Angermayer

Werner EngelhardtWerner EngelhardtCo-Founder · LacunaCraig AumannCraig AumannCo-Founder · Cvex GroupSultan MeghjiSultan MeghjiFounder · RevioJames WhitcombJames WhitcombFounder · Frontier RiskRicardo DonosoRicardo DonosoBoard Member · Manutara VenturesElliot O'ConnorElliot O'ConnorCo-Founder · Frontier Talent